NCT00422877 2025-10-16
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract
American Regent, Inc.
Phase 2 Terminated
Clinical Trials
4 trialsNCT00087776 2025-07-23
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
American Regent, Inc.
Phase 3 Terminated
NCT02521753 2025-04-01
OMgObPCOS
Coordinación de Investigación en Salud, Mexico
Phase NA Terminated
NCT05116878 2023-09-08
EFFORTS
Mayo Clinic
Phase NA Terminated